Yadong Biopharmaceutical

Heilongjiang Yadong Biopharmaceutical is a China-based pharmaceutical company that focuses on the development, manufacturing, and distribution of chemical drugs and traditional Chinese medicines. Established in 1994, the company has grown into a significant regional player with a product portfolio centered on cardiovascular, orthopedic, and metabolic health. Its lead commercial products include treatments for osteoarthritis, such as its signature chondroitin sulfate capsules, as well as generic formulations for diabetes and hypertension. Yadong Biopharmaceutical operates a large-scale manufacturing base in Harbin, which is equipped with modern production lines for various oral and injectable dosage forms. The company continues to invest in the modernization of traditional medicines while maintaining a robust supply chain for essential chemical generics.